Crescent Biopharma (C68.F) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-4.47
-3.35
-2.22
-1.1

Details

Expected EPS
-2.09414036484
Actual EPS
-3.3977531999999995
Surprise EPS
-1.3
Surprise Percent
+62.25%

Description

Crescent Biopharma (C68.F) has reported earnings of -3.3977531999999995 per share for Q1 2026.

0 Comments

Share your thoughts